The DAPA‐DIET study: Metabolic response to Dapagliflozin combined with dietary carbohydrate restriction in patients with Type 2 Diabetes Mellitus and Obesity—A longitudinal cohort study

OBJECTIVE: The cardio‐renal benefits of sodium glucose‐like transporter 2 inhibitor (SGLT2i) therapies have been demonstrated in patients with and without type 2 diabetes. However, no studies have explored the long‐term metabolic effects of SGLT2i, combined with dietary carbohydrate restriction. Our...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanson, Petra, Randeva, Harpal, Cuthbertson, Dan J., O'Hare, Paul J., Parsons, Nick, Chatha, Kamaljit, Reidy, Gemma, Weickert, Martin O., Barber, Thomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659664/
https://www.ncbi.nlm.nih.gov/pubmed/36266774
http://dx.doi.org/10.1002/edm2.381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659664/
https://www.ncbi.nlm.nih.gov/pubmed/36266774
http://dx.doi.org/10.1002/edm2.381

Ejemplares similares